Be the first to know when Wall Street analysts revise their BFRI stock forecasts and price targets.
Forecast return on equity
Is BFRI forecast to generate an efficient return?
Company
-72.36%
Industry
38.6%
Market
80.85%
BFRI's Return on Equity is forecast to be low in 4 years (-72.36%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast High Return on Equity Forecast
Forecast return on assets
Is BFRI forecast to generate an efficient return on assets?
BFRI
is forecast to generate lower Return on Assets (
15.95%
) than the
US
Drug Manufacturers - Specialty & Generic industry average (
17.38%
)
Forecast Return on Assets vs Industry Forecast
BFRI earnings per share forecast
What is BFRI's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$3.21
Avg 2 year Forecast
-$0.23
Avg 3 year Forecast
$0.41
BFRI revenue forecast
What is BFRI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$41.0M+23.24%
Avg 2 year Forecast
$53.9M+62.1%
Avg 3 year Forecast
$68.1M+104.8%
BFRI's revenue is forecast to grow at an exceptional rate of 26.99% per year
Forecast High Revenue Growth Forecast
BFRI revenue growth forecast
How is BFRI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
26.99%
Industry
7.68%
Market
9.87%
BFRI
's revenues are forecast to grow faster (
26.99%
per year) than the
US
Drug Manufacturers - Specialty & Generic industry average (
7.68%
)
Forecast Revenue Growth vs Industry Forecast
BFRI's revenues are forecast to grow faster (26.99% per year) than the US market average (9.87%)
Forecast Revenue Growth vs Market Forecast
